Pages that link to "Q26866001"

The following pages link to How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story (Q26866001):

Displaying 45 items.

• Unified theory of Alzheimer's disease (UTAD): implications for prevention and curative therapy (Q26382049) (← links)
• Repurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's disease (Q26748711) (← links)
• The Role of Autophagy, Mitophagy and Lysosomal Functions in Modulating Bioenergetics and Survival in the Context of Redox and Proteotoxic Damage: Implications for Neurodegenerative Diseases (Q26750137) (← links)
• Milk--A Nutrient System of Mammalian Evolution Promoting mTORC1-Dependent Translation (Q26801523) (← links)
• Therapeutic Manipulation of Ageing: Repurposing Old Dogs and Discovering New Tricks (Q28069996) (← links)
• Pim1 inhibition as a novel therapeutic strategy for Alzheimer's disease (Q28277112) (← links)
• WORMHOLE: Novel Least Diverged Ortholog Prediction through Machine Learning (Q28822241) (← links)
• The mammalian target of rapamycin at the crossroad between cognitive aging and Alzheimer's disease (Q33914286) (← links)
• Caloric restriction increases ketone bodies metabolism and preserves blood flow in aging brain (Q35688638) (← links)
• The endocytic pathway in microglia during health, aging and Alzheimer's disease (Q36078890) (← links)
• Rapamycin Increases Mortality in db/db Mice, a Mouse Model of Type 2 Diabetes (Q37000451) (← links)
• Reduced Incidence of Dementia in Solid Organ Transplant Patients Treated with Calcineurin Inhibitors (Q37044162) (← links)
• Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer's disease (Q37514713) (← links)
• Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology (Q38659874) (← links)
• Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer's disease. (Q38660086) (← links)
• Translating the Science of Aging into Therapeutic Interventions (Q38756902) (← links)
• Targeting mTOR to reduce Alzheimer-related cognitive decline: from current hits to future therapies (Q38815881) (← links)
• An overview of rapamycin: from discovery to future perspectives (Q38822715) (← links)
• Caloric restriction: beneficial effects on brain aging and Alzheimer's disease (Q38848268) (← links)
• The mTOR signalling cascade: paving new roads to cure neurological disease (Q38875632) (← links)
• Reversal of phenotypes of cellular senescence by pan-mTOR inhibition. (Q38964715) (← links)
• mTOR referees memory and disease through mRNA repression and competition (Q39298436) (← links)
• mTOR: Alzheimer's disease prevention for APOE4 carriers (Q42333575) (← links)
• PPAR Gamma Coactivator 1 Beta (PGC-1β) Reduces Mammalian Target of Rapamycin (mTOR) Expression via a SIRT1-Dependent Mechanism in Neurons (Q46489201) (← links)
• Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment (Q47851530) (← links)
• mTOR in Down syndrome: Role in Aß and tau neuropathology and transition to Alzheimer disease-like dementia (Q47953822) (← links)
• Hypertension impairs neurovascular coupling and promotes microvascular injury: role in exacerbation of Alzheimer's disease. (Q54192569) (← links)
• The Geropathology Grading Platform demonstrates that mice null for Cu/Zn-superoxide dismutase show accelerated biological aging. (Q55002835) (← links)
• Neuroimaging Biomarkers of mTOR Inhibition on Vascular and Metabolic Functions in Aging Brain and Alzheimer's Disease (Q57174537) (← links)
• Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome (Q58609012) (← links)
• Rapamycin Treatment Ameliorates Age-Related Accumulation of Toxic Metabolic Intermediates in Brains of the Ts65Dn Mouse Model of Down Syndrome and Aging (Q58761442) (← links)
• IgM response against amyloid-beta in aging: a potential peripheral protective mechanism (Q58773839) (← links)
• The Way Forward: Translation (Q60358611) (← links)
• The role of DNA methylation in epigenetics of aging (Q64121471) (← links)
• Antibiotics, gut microbiota, and Alzheimer's disease (Q64275470) (← links)
• Genetic heterogeneity of Alzheimer's disease in subjects with and without hypertension. (Q64911453) (← links)
• Everolimus, a mammalian target of rapamycin inhibitor, ameliorated streptozotocin-induced learning and memory deficits via neurochemical alterations in male rats. (Q65002070) (← links)
• LncRNA GUARDIN suppresses cellular senescence through a LRP130-PGC1α-FOXO4-p21-dependent signaling axis (Q90154670) (← links)
• Telomerase Biology Associations offer Keys to Cancer and Aging Therapeutics (Q90211132) (← links)
• APOE genotype-dependent pharmacogenetic responses to rapamycin for preventing Alzheimer's disease (Q90337790) (← links)
• Is Rapamycin a Dietary Restriction Mimetic? (Q92258549) (← links)
• Ketamine: A Neglected Therapy for Alzheimer Disease (Q92510468) (← links)
• Causative Links between Protein Aggregation and Oxidative Stress: A Review (Q92570368) (← links)
• Traditional Chinese Medicine: Role in Reducing β-Amyloid, Apoptosis, Autophagy, Neuroinflammation, Oxidative Stress, and Mitochondrial Dysfunction of Alzheimer's Disease (Q94544697) (← links)
• The quest to slow ageing through drug discovery (Q95936711) (← links)